NCT01263236View on ClinicalTrials.gov

A Study of LY2940094 in Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Major Depressive Disorder
Interventions
DRUG

LY2940094

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

M5V 2T3

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Toronto

Sponsors
All Listed Sponsors
lead

BlackThorn Therapeutics, Inc.

INDUSTRY